| pubmed-article:21797111 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21797111 | lifeskim:mentions | umls-concept:C1140680 | lld:lifeskim |
| pubmed-article:21797111 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:21797111 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:21797111 | lifeskim:mentions | umls-concept:C0302600 | lld:lifeskim |
| pubmed-article:21797111 | lifeskim:mentions | umls-concept:C0039736 | lld:lifeskim |
| pubmed-article:21797111 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:21797111 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:21797111 | lifeskim:mentions | umls-concept:C0086589 | lld:lifeskim |
| pubmed-article:21797111 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:21797111 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:21797111 | lifeskim:mentions | umls-concept:C1708063 | lld:lifeskim |
| pubmed-article:21797111 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:21797111 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:21797111 | pubmed:dateCreated | 2011-7-29 | lld:pubmed |
| pubmed-article:21797111 | pubmed:abstractText | To compare the safety and efficacy of thalidomide in combination with carboplatin to carboplatin alone as a first-line therapy in women with ovarian cancer and to evaluate the anti-angiogenic effects of thalidomide by measurement of surrogate markers of angiogenesis. | lld:pubmed |
| pubmed-article:21797111 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21797111 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21797111 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21797111 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21797111 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21797111 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21797111 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21797111 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21797111 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21797111 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21797111 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21797111 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21797111 | pubmed:issn | 0392-2936 | lld:pubmed |
| pubmed-article:21797111 | pubmed:author | pubmed-author:HanCC | lld:pubmed |
| pubmed-article:21797111 | pubmed:author | pubmed-author:KaulUU | lld:pubmed |
| pubmed-article:21797111 | pubmed:author | pubmed-author:JenkinsAA | lld:pubmed |
| pubmed-article:21797111 | pubmed:author | pubmed-author:BlannA DAD | lld:pubmed |
| pubmed-article:21797111 | pubmed:author | pubmed-author:GanesanT STS | lld:pubmed |
| pubmed-article:21797111 | pubmed:author | pubmed-author:PerrenTT | lld:pubmed |
| pubmed-article:21797111 | pubmed:author | pubmed-author:WilnerSS | lld:pubmed |
| pubmed-article:21797111 | pubmed:author | pubmed-author:BraybrookeJ... | lld:pubmed |
| pubmed-article:21797111 | pubmed:author | pubmed-author:MadhusudanSS | lld:pubmed |
| pubmed-article:21797111 | pubmed:author | pubmed-author:Muthuramaling... | lld:pubmed |
| pubmed-article:21797111 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:21797111 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:21797111 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21797111 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21797111 | pubmed:pagination | 253-8 | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:meshHeading | pubmed-meshheading:21797111... | lld:pubmed |
| pubmed-article:21797111 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21797111 | pubmed:articleTitle | A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis. | lld:pubmed |
| pubmed-article:21797111 | pubmed:affiliation | Cancer Research UK Medical Oncology Unit, University of Oxford, Churchill Hospital, Oxford. | lld:pubmed |
| pubmed-article:21797111 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21797111 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:21797111 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21797111 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
